Chronic Fatigue Syndrome/Myalgic Encephalomyelitis : Diagnosis and Treatment

doi:10.3390/books978-3-0365-5970-4

Download Url(s)

https://mdpi.com/books/pdfview/book/6613

Contributor(s)

Ricevuti, Giovanni (editor)

Lorusso, Lorenzo (editor)

Language

English

Show full item record

Abstract

This Special Issue on CFS/ME collects 18 papers with an interdisciplinary view on the current demographic and epidemiological data and immunological characteristics of CFS/ME and examines the different pathogenic hypotheses, as well as giving information about the latest knowledge on diagnostic investigations, pharmacological, integrative, physical, cognitive-behavioral and psychological curative approaches.

URI

https://directory.doabooks.org/handle/20.500.12854/96668

Keywords

chronic fatigue syndrome; myalgic encephalomyelitis; RCT; measurement; cardiopulmonary exercise test; postexertional malaise; fibromyalgia; dual task; MMSE; MoCA; TUG; cognitive; autonomic nervous system; exercise; mitofusin; oxygen consumption; PEM; brain fog; vascular stiffness; autoimmunity; immunology; IgG replacement; IgG deficiency; biomarker; ME/CFS; COVID-19; diagnostic; impact on society; myalgic encephalomyelitis/chronic fatigue syndrome; routine blood tests; diagnostic criteria; functional status; creatinine; creatine kinase; CFS; prevalence; Korea and Japan; meta-analysis; EEG; fast Fourier transform; diagnosis; ROC curve; follow-up; adolescence; health; wellbeing; adrenergic receptors; autoantibodies; vasoregulation; G-protein-coupled receptor; exercise for well-being; active exercise program; flexibility; static balance; pain; quality of life; C1q; complement system; blood analytics; symptoms; cluster analysis; autonomic function; electrodermal activity; electrocardiogram; heart rate; immunity; dysbiosis; hormone; depression; genetics; miRNA; therapy; intestinal permeability; metabolic endotoxemia; LPS; ozone; oxygen–ozone therapy; fatigue; clinical trial; n/a